LivaNova (FRA:LIA) Total Membership (K): 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LIA LivaNova PLC FRA:LIA
76 GF Score
Price €68.00
GF Value €54.88
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is LivaNova Total Membership (K)?

LivaNova FRA:LIA -0.73% 76 Total Membership (K) is 0.00 as of . 20. GuruFocus rates FRA:LIA with a GF Score™ of 76/100 and a GF Value™ of €54.88 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Total Membership (K) is the total number of people who purchase the insurance plan to cover their medical expenses. A higher Total Membership (K) number indicates that the company is more likely to generate a higher revenue.

The historical rank and industry rank for LivaNova's Total Membership (K) or its related term are showing as below:

FRA:LIA's Total Membership (K) is not ranked *
in the Medical Devices & Instruments industry.
Industry Median:
* Ranked among companies with meaningful Total Membership (K) only.

LivaNova  (FRA:LIA) Total Membership (K) Explanation

Total Membership (K) is the total number of people who purchase the insurance plan to cover their medical expenses.

A higher Total Membership (K) number indicates that the company is more likely to generate a higher revenue.

LivaNova Total Membership (K) Related Terms

LivaNova Total Membership (K) Historical Data

* Premium members only.

The historical data trend for LivaNova's Total Membership (K) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LivaNova Total Membership (K) Chart


FRA:LIA
76GF Score
LivaNova PLC FRA:LIA
Total Membership (K) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions
What does a Total Membership (K) of 0.00 mean?
LivaNova (FRA:LIA) has a Total Membership (K) of 0.00 as of . 20. The total number of people who purchase the insurance plan to cover their medical expenses. A higher total membership number indicates that the company is more likely to generate a higher revenue. View historical data on LivaNova and its competitors.
Is LivaNova's Total Membership (K) too high?
LivaNova's current Total Membership (K) is 0.00. Overall, LivaNova has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LivaNova's Total Membership (K) compare to ITGR and HAE?
LivaNova's Total Membership (K) of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Membership (K) for a Medical Devices & Instruments company?
A good Total Membership (K) depends on the Medical Devices & Instruments industry context. However, Total Membership (K) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Membership (K) mean?
A high Total Membership (K) can signal that a stock is expensive relative to its fundamentals. The total number of people who purchase the insurance plan to cover their medical expenses. A higher total membership number indicates that the company is more likely to generate a higher revenue. View historical data on LivaNova and its competitors. LivaNova's current Total Membership (K) is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LivaNova stock overvalued right now?
Based on GuruFocus' analysis, LivaNova (FRA:LIA) is currently considered Modestly Overvalued. The stock's GF Value™ is €54.88, compared to a current price of €68.00 — trading 23.9% above its estimated fair value. The current Total Membership (K) is 0.00. LivaNova's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Membership (K) calculated?
Total Membership (K) is calculated from a company's financial statements. For LivaNova (FRA:LIA), the current Total Membership (K) is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LivaNova (FRA:LIA) Overvalued in 2026?

Based on GuruFocus' analysis, LivaNova stock appears to be overvalued. The current stock price of €68.00 is trading 23.9% above its estimated GF Value™ of €54.88. GuruFocus considers LivaNova to be Modestly Overvalued.

Key valuation signals for FRA:LIA:

  • Total Membership (K): 0.00
  • GF Value™: €54.88 vs. price of €68.00 (23.9% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the FRA:LIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LivaNova Business Description

Other Exchanges LIVN:USA
Address 20 Eastbourne Terrace, London, GBR, W2 6LG
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
76GF Score

Get the complete analysis for FRA:LIA

Total Membership (K) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€68.00
Price
€54.88
GF Value